Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Dae Hyun Yoo, Choongseob Oh, SeungSuh Hong & Won Park. (2015) Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product. Expert Review of Clinical Immunology 11:sup1, pages 15-24.
Read now
Read now
Nilufer Ilhan, Nilgul Ustun, Esra Ayhan Tuzcu, Mesut Coskun, Abdullah Erman Yagiz, Ozgur Ilhan & Nihan Parlakfikirer. (2015) Spectral domain-optical coherence tomographic findings in patients with ankylosing spondylitis under anti-tumor necrosis factor-alpha therapy. Cutaneous and Ocular Toxicology 34:3, pages 222-226.
Read now
Read now
Carlo Palazzi, Angela Padula, Maria Montaruli, Ernesta Pennese & Ignazio Olivieri. (2006) Pharmacological management of undifferentiated spondyloarthropathies. Expert Opinion on Investigational Drugs 15:1, pages 39-46.
Read now
Read now
J. Braun, X. Baraliakos, J. Brandt & J. Sieper. (2005) Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides. Scandinavian Journal of Rheumatology 34:3, pages 178-190.
Read now
Read now
Daniel Wendling & Eric Toussirot. (2004) Anti-TNF-α therapy in ankylosing spondylitis. Expert Opinion on Pharmacotherapy 5:7, pages 1497-1507.
Read now
Read now
Articles from other publishers (23)
Rajeshwar Nath Srivastava, Shatakshi Pant, Sudeepti Ratan Srivastava, Amar Chandra Sharma & Saloni Raj. 2022. Ankylosing Spondylitis [Working Title]. Ankylosing Spondylitis [Working Title].
M. H. Al-Mossawi, L. Chen, H. Fang, A. Ridley, J. de Wit, N. Yager, A. Hammitzsch, I. Pulyakhina, B. P. Fairfax, D. Simone, Yao Yi, S. Bandyopadhyay, K. Doig, R Gundle, B. Kendrick, F. Powrie, J. C. Knight & P. Bowness. (2017) Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nature Communications 8:1.
Crossref
Crossref
Denis Wakefield, Gregory Carr & Peter McCluskey. 2016. Intraocular Inflammation. Intraocular Inflammation
703
711
.
Mariagrazia Lorenzin, Augusta Ortolan, Paola Frallonardo, Francesca Oliviero, Leonardo Punzi & Roberta Ramonda. (2015) Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab. BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Narender Annapureddy, Shiv Kumar Agarwal, Natraj Ammakkanavar, Vijay Kanakadandi, Manpreet S. Sabharwal, Hari Priya Sanjani, Priya Simoes & Girish N. Nadkarni. (2014) Tumor Necrosis Factor Inhibitor–Induced Serositis. American Journal of Therapeutics 21:5, pages e166-e168.
Crossref
Crossref
Melissa J. Lamberson & Douglas W. Lowery-North. 2012. An Introduction to Clinical Emergency Medicine. An Introduction to Clinical Emergency Medicine
437
448
.
Ioanna Saougou, Theodora E. Markatseli, Paraskevi V. Voulgari & Alexandros A. Drosos. (2010) Maintien de la réponse clinique au traitement par infliximab au cours de la spondylarthrite ankylosante : suivi à six ans. Revue du Rhumatisme 77:5, pages 480-484.
Crossref
Crossref
Ioanna Saougou, Theodora E. Markatseli, Paraskevi V. Voulgari & Alexandros A. Drosos. (2010) Maintained clinical response of infliximab treatment in ankylosing spondylitis: A 6-year long-term study. Joint Bone Spine 77:4, pages 325-329.
Crossref
Crossref
ROBERT D. INMAN & WALTER P. MAKSYMOWYCH. (2010) A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis. The Journal of Rheumatology 37:6, pages 1203-1210.
Crossref
Crossref
Kaapjoo Park, Ariamala Gopalsamy, Alexis Aplasca, John W. Ellingboe, Weixin Xu, Yuhua Zhang & Jeremy I. Levin. (2009) Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-α converting enzyme (TACE) inhibitors. Bioorganic & Medicinal Chemistry 17:11, pages 3857-3865.
Crossref
Crossref
Maqsood M. Elahi, Kamlesh Asotra, Bashir M. Matata & Sarabjit S. Mastana. (2009) Tumor necrosis factor alpha −308 gene locus promoter polymorphism: An analysis of association with health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1792:3, pages 163-172.
Crossref
Crossref
Prashant R. Murumkar, Shirshendu Das Gupta, Vishal P. Zambre, Rajani Giridhar & Mange Ram Yadav. (2009) Development of Predictive 3D-QSAR CoMFA and CoMSIA Models for β-aminohydroxamic Acid-Derived Tumor Necrosis Factor-α Converting Enzyme Inhibitors. Chemical Biology & Drug Design 73:1, pages 97-107.
Crossref
Crossref
Zai-xing YANG. (2008) Expression of serum soluble TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis and its clinical significance. Academic Journal of Second Military Medical University 28:1, pages 68-71.
Crossref
Crossref
Zhenhua Xu, Kathleen Seitz, Adedigbo Fasanmade, Joyce Ford, Paul Williamson, Weichun Xu, Hugh M. Davis & Honghui Zhou. (2008) Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis. The Journal of Clinical Pharmacology 48:6, pages 681-695.
Crossref
Crossref
James E. SheppeckIIII, John L. Gilmore, Andrew Tebben, Chu-Biao Xue, Rui-Qin Liu, Carl P. Decicco & James J.-W. Duan. (2007) Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters 17:10, pages 2769-2774.
Crossref
Crossref
James E. SheppeckIIII, John L. Gilmore, Anle Yang, Xiao-Tao Chen, Chu-Biao Xue, John Roderick, Rui-Qin Liu, Maryanne B. Covington, Carl P. Decicco & James J.-W. Duan. (2007) Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters 17:5, pages 1413-1417.
Crossref
Crossref
James E. SheppeckIIII, Andrew Tebben, John L. Gilmore, Anle Yang, Zelda R. Wasserman, Carl P. Decicco & James J.-W. Duan. (2007) A molecular modeling analysis of novel non-hydroxamate inhibitors of TACE. Bioorganic & Medicinal Chemistry Letters 17:5, pages 1408-1412.
Crossref
Crossref
Yi-Yang Yvonne Li, Yang Yang, Ming Bao, Carl K. EdwardsIIIIII & Jane R. Parnes. (2006) Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-α nuclear pre-mRNA. Molecular Immunology 43:6, pages 613-622.
Crossref
Crossref
Marvi Iqbal & Michael S. Kolodney. (2005) Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. Journal of the American Academy of Dermatology 52:5, pages S118-S120.
Crossref
Crossref
D�sir�e van der Heijde, Ben Dijkmans, Piet Geusens, Joachim Sieper, Kimberly DeWoody, Paul Williamson & J�rgen Braun. (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT). Arthritis & Rheumatism 52:2, pages 582-591.
Crossref
Crossref
Henning Zeidler, Jens Kuipers & Lars Köhler. (2004) Chlamydia-induced arthritis. Current Opinion in Rheumatology 16:4, pages 380-392.
Crossref
Crossref
C Desgranges. (2004) Anticorps monoclonaux et thérapeutique. Pathologie Biologie 52:6, pages 351-364.
Crossref
Crossref
Xenofon Baraliakos & Juergen Braun. (2004) Current Concepts in the Therapy of the Spondyloarthritides. BioDrugs 18:5, pages 307-314.
Crossref
Crossref